News

Opioids are often used in combination with other analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) in particular. With the discovery of an increased risk of cardiovascular events affecting popular COX-2

The VI Technologies (Vitex) shareholders also approved all other resolutions related to the merger, including the issuance of shares and warrants as part of a $20 million private

The primary objective of the phase II clinical trial was to compare the speed of absorption of ibuprofen into the bloodstream of a 400mg dose of ZAG-1701 with

New Mexican regulatory policies require that any advertising making medical claims must have prior approval from the Mexican national regulator, explained Biotech Holdings’ president and director, Robert Rieveley.

The $3.1 million phase II small business innovation research (SBIR) grant supplements the $1 million awarded to Vical in 2004 for the cytomegalovirus (CMV) vaccine program under two

The trial, named EVEREST, is a multi-center clinical trial that will assess the efficacy of retreatment with Velcade (bortezomib) for injection in terms of best confirmed M-protein response.

According to the World Health Organization (WHO), there have been 55 cases with 42 laboratory-confirmed deaths from the H5N1 avian influenza virus between January 28, 2004 and February

The study, for which Perlegen was awarded a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), aims to provide greater insight into the

On November 23, 2004, Inyx announced it was awarded an exclusive five-year contract to produce NovaDel’s nitroglycerin lingual spray for the treatment of acute angina, the first of